홈/주식/DNTH

DNTH

USD

Dianthus Therapeutics Inc. Common Stock

$33.200-0.690 (-2.036%)

실시간 가격

Healthcare

생명공학

미국

가격 차트

Loading Chart...

핵심 지표

시장 지표

기업 기본 정보

거래 통계

시장 지표

시가

$33.890

고가

$34.110

저가

$32.960

거래량

0.43M

기업 기본 정보

시가총액

1.3B

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.69M

거래소

NCM

통화

USD

52주 범위

저가 $13.37현재가 $33.200고가 $40.16

관련 뉴스

2025년 10월 29일 · 오후 07:30

GlobeNewswire

Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting

Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing Phase 3 gMG trial planned

Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting

2025년 10월 14일 · 오후 01:07

Analyst Upgrades

Truist Securities Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $56

Truist Securities analyst Danielle Brill initiates coverage on Dianthus Therapeutics with a Buy rating and announces Price Target of $56.

Truist Securities Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $56

관련 주식

VACHU

Voyager Acquisition Corp Unit

NASDAQ

CNOBP

ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A

NASDAQ

주요 은행